C33 RESEARCH AUDIO ◉ 7:14

BPC-157: Gastrointestinal & Tendon Research Models

Educational Research Discussion

00:00

An educational audio discussion examining BPC-157 research in gastrointestinal and tendon-related experimental models.

AI-narrated educational discussion prepared from cited research sources and reviewed for inclusion in the C33 Research Library.

C³³ | Recovery Research — Compound Profile

BPC-157 is a synthetic pentadecapeptide derived from a partial sequence identified in human gastric juice. In controlled laboratory research environments, BPC-157 is characterized for its stability in aqueous and acidic conditions, peptide-receptor interaction behavior, and use as a reference compound in structural peptide research.

Each vial contains lyophilized BPC-157 powder. Purity, identity, and net content are analytically verified and documented on the lot-specific Certificate of Analysis. Current COA results vary by tested batch and product variant.

For laboratory and research purposes only. Not for human or veterinary use.

C33 LAB PREPARATION

Reconstitution solution

This product is supplied as lyophilized powder. A suitable reconstitution solution is required for laboratory preparation and is not included with this product. If you already have an appropriate solution, no additional purchase is necessary. Otherwise, add the C33 Reconstitution Solution before checkout.

View Bacteriostatic Water →
Bacteriostatic Water
LAB PREPARATION Bacteriostatic Water $8.00 View solution →
C33 COMPOUND DATA

Research specifications

COMPOUNDBPC-157
CAS NUMBER137525-51-0
MOLECULAR FORMULAC62H98N16O22
MOLECULAR WEIGHT1419.5 g/mol
PUBCHEM CID9941957
FORMLyophilized powder
APPEARANCEWhite lyophilized powder
SOLUBILITYSoluble in bacteriostatic or sterile water
SEQUENCEGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
C33 LOT-SPECIFIC DOCUMENTATION

Independent lab testing

Purity, identity, and net content are documented on lot-specific Certificates of Analysis. Current results vary by tested batch and product variant.

SELECTED VARIANT5MG
Current
LOT / BATCHBC549
PURITY99.56%
IDENTITYConfirmed
TESTED CONTENT / MASS6.3 mg
LABORATORYFreedom Diagnostics
REPORT DATEJune 15, 2026
ANALYTICAL METHODHPLC with UV detection coupled with mass spectrometry (LC-MS).
SELECTED VARIANT10MG
Current
LOT / BATCHBC1049
PURITY99.68%
IDENTITYConfirmed
TESTED CONTENT / MASS11.93 mg
LABORATORYFreedom Diagnostics
REPORT DATEJune 15, 2026
ANALYTICAL METHODHPLC with UV detection coupled with mass spectrometry (LC-MS).
C33 HANDLING

Storage guidelines

Unreconstituted: Store at -20°C for long-term stability or at 2–8°C for shorter-term storage. Protect from light and moisture. Avoid repeated freeze-thaw cycles.

C33 RESEARCH LIBRARY

Research focus

  • Structural peptide research
  • peptide stability
  • peptide-receptor interactions
  • tissue-signaling pathways
  • angiogenesis-related research
  • cytoprotective mechanisms.

Selected published literature is maintained separately in the References tab so research context and source material remain easy to distinguish.

C33 SOURCE MATERIAL

Selected published research

Sikiric P, et al. (2020). Stable Gastric Pentadecapeptide BPC 157: Robert's Cytoprotection/Organoprotection. PMID: 31158953.

Seiwerth S, Sikiric P, et al. (2014). BPC 157 and blood vessels. Curr Pharm Des. 20(7):1121-1125. PMID: 23755725.

C33 CERTIFICATE ACCESS

Certificate of Analysis

Certificate access follows the currently selected product variant so the displayed lot documentation always matches the selected potency or configuration.

CURRENT SELECTION

BPC-157 — 5MG

LOT / BATCHBC549
PURITY99.56%
REPORT DATEJune 15, 2026
CURRENT SELECTION

BPC-157 — 10MG

LOT / BATCHBC1049
PURITY99.68%
REPORT DATEJune 15, 2026
RESEARCH USE ONLY For laboratory and research purposes only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or clinical application.